Foundation Fighting Blindness

Atsena to Launch Part B of Phase 1/2 Clinical Trial for XLRS Gene Therapy


Episode Artwork
1.0x
0% played 00:00 00:00
Jan 09 2025 4 mins   4
Other Episodes
The Foundation is a founding investor in Atsena.
Download episode Share
Copy URL



Listen on Podcast Addict
Subscribe on Podcast Addict